Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
2.
J Hosp Infect ; 115: 1-4, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34048849

ABSTRACT

A survey was undertaken to evaluate the level of computerization in intensive care units (ICUs) within a French network dedicated to the surveillance of healthcare-associated infections, antimicrobial use (AMU) and antimicrobial resistance (AMR) in ICUs (REA-REZO). Ninety-eight ICUs responded, and patient records were computerized in 57%, antimicrobial prescriptions were computerized in 59% and AMR epidemiology was computerized in 72%. AMU and AMR feedback was provided to the ICU itself for 77% and 65% of ICUs, respectively, and feedback was provided to the national surveillance for 79% and 65% of ICUs, respectively. This study suggests that the level of computerization in ICUs requires further improvement.


Subject(s)
Anti-Infective Agents , Cross Infection , Anti-Bacterial Agents/therapeutic use , Cross Infection/drug therapy , Cross Infection/epidemiology , Cross Infection/prevention & control , Humans , Intensive Care Units , Prohibitins , Surveys and Questionnaires
3.
Int J Hyperthermia ; 37(1): 897-902, 2020.
Article in English | MEDLINE | ID: mdl-32689832

ABSTRACT

BACKGROUND: Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has been shown to provide benefits in the management of peritoneal metastasis. Cisplatin (CDDP) is one of the most frequently used drugs for peritoneal infusion. A major restriction is that CDDP causes renal toxicity and acute renal failure, sometimes leading to chronic renal failure. The aim of the present study was to assess the impact of sodium thiosulfate (ST) in preventing renal impairment (RI) following HIPEC with CDDP. METHODS: This prospective study assessed the RI rates for all patients who underwent HIPEC with CDDP during two successive periods: without ST (nST Period; from November 2016 to September 2017) and with ST (ST Period; from October 2017 to March 2018). During the ST Period, patients received an ST infusion at 9 mg/m2 prior to HIPEC and at 12 mg/m2 at the end of the procedure. RI was defined by postoperative serum creatinine >1.6 times elevation of baseline value. The impact of ST treatment was evaluated by comparison of the RI rates between the two periods. RESULTS: During ST Period, none of 38 patients (0%) developed RI versus 11/35 patients (31.4%) during the nST Period (p < .005); 2 of whom required definitive hemodialysis. Baseline characteristics, background circumstances, indications and laboratory parameters before HIPEC were comparable between the two groups, as well as CDDP dose use during HIPEC. CONCLUSION: ST appears to be an effective drug for the prevention of the renal toxicity of CDDP used for HIPEC and should be used for all such procedures.


Subject(s)
Antineoplastic Agents , Hyperthermia, Induced , Antineoplastic Agents/adverse effects , Antineoplastic Combined Chemotherapy Protocols , Cisplatin/adverse effects , Combined Modality Therapy , Cytoreduction Surgical Procedures , Humans , Hyperthermia, Induced/adverse effects , Hyperthermic Intraperitoneal Chemotherapy , Prospective Studies , Thiosulfates
5.
Eur J Surg Oncol ; 42(6): 855-60, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27061789

ABSTRACT

BACKGROUND: Cytoreductive surgery (CRS) and Hyperthermic intraperitoneal chemotherapy (HIPEC) are promising new approaches of peritoneal metastases. However these surgical procedures are associated with a high morbidity rate thus intensive care (IC) management following serious complications may be warranted for these patients. The impact of the prolonged IC stay or re-admission on long-term survival remains unknown. METHODS: We retrospectively analysed 122 consecutive HIPEC procedures over a one year period (2010-2011) in a single academic hospital. We analysed complications that would lead to prolonged stay or re-admission into ICU and analysed long term follow-up in patients whether they required intensive care (ICU group) or not (Control group). RESULTS: ICU group represented 26.2% of the cohort mainly due to septic or haemorrhagic shock. Among them acute kidney injury and respiratory failure were present in 50% and 47% respectively. Cohort overall mortality rate was of 5.7%. Patients were followed for 4 years and survival analysis was performed adjusting for main confounding factors in a Cox survival model. Survival was not different between groups, with a median survival of 38 months [32; 44] vs. 33 months [26; 39] in the ICU group and Control group respectively. CONCLUSION: Prolonged stay or re-admission into ICU does not seem to statistically impact long term prognosis of patients undergoing CRS with HIPEC.


Subject(s)
Chemotherapy, Cancer, Regional Perfusion , Cytoreduction Surgical Procedures , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Chemotherapy, Adjuvant , Combined Modality Therapy , Follow-Up Studies , Humans , Hyperthermia, Induced , Intensive Care Units , Neoplasm Staging , Peritoneal Neoplasms , Survival Rate
11.
Ann Fr Anesth Reanim ; 32(9): 615-7, 2013 Sep.
Article in French | MEDLINE | ID: mdl-23948025

ABSTRACT

Bacterial parotitis is a common childhood disease with a favorable outcome. Staphylococcus aureus is the most frequently involved pathogen. Clinical presentation in adult patients can be misleading, Onset occurs in patients with multiple comorbidities, making diagnosis difficult--particularly in ICU. Different pathogens are found in adults with worse outcomes observed. We report here the case of a critically ill patient and discuss diagnosis and management of bacterial parotitis.


Subject(s)
Critical Care/methods , Immunocompromised Host , Parotitis/microbiology , Parotitis/therapy , Pseudomonas Infections/microbiology , Pseudomonas Infections/therapy , Aged , Anti-Bacterial Agents/therapeutic use , Electroencephalography , Humans , Immunosuppressive Agents/adverse effects , Immunosuppressive Agents/therapeutic use , Magnetic Resonance Imaging , Male , Microbial Sensitivity Tests , Parotid Gland/pathology , Parotitis/drug therapy , Pseudomonas Infections/drug therapy , Pseudomonas aeruginosa/drug effects , Staphylococcal Infections/diagnosis , Tacrolimus/adverse effects , Tacrolimus/therapeutic use
12.
Ann Fr Anesth Reanim ; 31(10): 783-7, 2012 10.
Article in French | MEDLINE | ID: mdl-22784474

ABSTRACT

OBJECTIVE: Storage of cisatracurium at room temperature seems to have no effect on its degradation in vitro contrary to the recommendations of storage at +4°C. The purpose of this study was to evaluate the influence of cisatracurium' s storage temperature on its onset time. STUDY DESIGN: Prospective, randomized, double-blind trial study. PATIENTS AND METHODS: Thirty patients were enrolled. The control group consisted of 15 patients receiving cisatracurium (0.15mg/kg) stored at room temperature and the intervention consisted of 15 patients receiving cisatracurium (0.15mg/kg) stored at +4°C. The primary endpoint was to compare cisatracurium onset time depending on the storage temperature. RESULTS: Cisatracurium onset time was 235 (180-292) seconds in the "room temperature" group vs. 240 (210-292) seconds in the "refrigerated" group. There was no difference between the onset of cisatracurium depending on the temperature of storage (p=0.51). Subgroups analysis in the "room temperature" group did not show any difference in cisatracurium onset depending on whether it was stored at room temperature for one, two or three weeks. Excellent intubation score was obtained for 100% of the patients. CONCLUSION: This study demonstrated that cisatracurium's storage at room temperature had no influence on its onset time. It provides an argument for the preservation of cisatracurium at room temperature for a period not exceeding 21 days. Monitoring the onset of curarization may increase the quality score of intubation.


Subject(s)
Anesthesia , Atracurium/analogs & derivatives , Drug Storage , Neuromuscular Nondepolarizing Agents/chemistry , Adult , Aged , Atracurium/chemistry , Double-Blind Method , Drug Stability , Endpoint Determination , Female , Humans , Intubation, Intratracheal , Male , Middle Aged , Prospective Studies , Refrigeration , Temperature
13.
Ann Fr Anesth Reanim ; 25(7): 735-40, 2006 Jul.
Article in French | MEDLINE | ID: mdl-16698229

ABSTRACT

Brain microdialysis allows the exploration of brain extracellular medium. This review discusses the main contribution of brain microdialysis for the knowledge of the pathophysiology of brain ischemia and trauma. We describe fundamental principle of microdialysis, limits, and validated metabolic parameters as the lactate/pyruvate ratio or glycerol. The interest to use microdialysis for testing metabolic hypothesis and potential scientific research ways will also be discussed.


Subject(s)
Brain Injuries/diagnosis , Microdialysis , Animals , Brain Injuries/metabolism , Brain Injuries/physiopathology , Brain Ischemia/diagnosis , Brain Ischemia/metabolism , Brain Ischemia/physiopathology , Extracellular Space/metabolism , Humans
16.
J Am Chem Soc ; 123(26): 6388-95, 2001 Jul 04.
Article in English | MEDLINE | ID: mdl-11427065

ABSTRACT

The synthesis of surface-confined, nanometer-sized dendrimers and Au nanoparticles was performed starting from single Pd(II) pincer adsorbate molecules (10) embedded as isolated species into 11-mercapto-1-undecanol and decanethiol self-assembled monolayers (SAMs) on gold. The coordination of monolayer-protected Au nanoclusters (MPCs) bearing phosphine moieties at the periphery (13), or dendritic wedges (8) having a phosphine group at the focal point, to SAMs containing individual Pd(II) pincer molecules was monitored by tapping mode atomic force microscopy (TM AFM). The individual Pd(II) pincer molecules embedded in the decanethiol SAM were visualized by their coordination to phosphine MPCs 13; isolated objects with a height of 3.5 +/- 0.7 nm were observed by TM AFM. Reaction of these embedded Pd(II) pincer molecules with the dendritic wedge 8 yielded individual molecules with a height of 4.3 +/- 0.2 nm.

17.
Chem Commun (Camb) ; (23): 2434-5, 2001 Dec 07.
Article in English | MEDLINE | ID: mdl-12240001

ABSTRACT

Gelator-catalyst interactions allow the transcription of the organogel structure of methyl-4,6-O-(p-nitrobenzylidene)-alpha-D-glucopyranoside (1) into its silica analogue, even in the absence of positive charges or H-bonding sites on the gelator molecule which, until now, were considered indispensable.

18.
Angew Chem Int Ed Engl ; 38(15): 2248-2251, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10425499

ABSTRACT

The incorporation of dialkyl sulfide side chains in metallodendrimers is a simple method for their insertion into a monolayer of decanethiol formed by self-assembly on a gold surface. The dendrimer binds through the sulfide group to a defect in the monolayer on the gold surface (see picture). The surface concentration of the isolated dendrimer adsorbate can be regulated by the adsorption time (for example, 55 adsorbates on a surface of 200x200 nm(2) after 20 h).

SELECTION OF CITATIONS
SEARCH DETAIL
...